Exact Mass: 577.1346

Exact Mass Matches: 577.1346

Found 18 metabolites which its exact mass value is equals to given mass value 577.1346, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Clazosentan

N-[6-(2-Hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-1,2,3,4-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-methylpyridine-2-sulphonamide

C25H23N9O6S (577.1492)


C28313 - Endothelin Receptor Antagonist Clazosentan (Ro 61-1790) is a selective endothelin A (ETA) receptor antagonist. Clazosentan inhibits ET-1-mediated vasoconstriction. Clazosentan prevents cerebral vasospasm, vasospasm-related cerebral infarction[1][5].

   
   

sodium 4-[4-[[3-[(ethylanilino)sulphonyl]-4-methylphenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate

sodium 4-[4-[[3-[(ethylanilino)sulphonyl]-4-methylphenyl]azo]-4,5-dihydro-3-methyl-5-oxo-1H-pyrazol-1-yl]benzenesulphonate

C25H24N5NaO6S2 (577.1066)


   

Fmoc-Asp(OtBu)-Opfp

Fmoc-Asp(OtBu)-Opfp

C29H24F5NO6 (577.1524)


   

NAPHTHOL AS-MX-PHOSPHATE DISODIUM SALT NONAHYDRATE

NAPHTHOL AS-MX-PHOSPHATE DISODIUM SALT NONAHYDRATE

C19H34NNa2O14P (577.1512)


   

4-Nitro-Z-Gly-Cys(7-nitro-benzo[2,1,3]oxadiazol-4-yl)-Gly-OH

4-Nitro-Z-Gly-Cys(7-nitro-benzo[2,1,3]oxadiazol-4-yl)-Gly-OH

C21H19N7O11S (577.0863)


   

Tebipenem pivoxil hydrobromide

Tebipenem pivoxil hydrobromide

C22H32BrN3O6S2 (577.0916)


D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D047090 - beta-Lactams D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D007769 - Lactams C2140 - Adjuvant > C183118 - Beta-lactamase Inhibitor

   

Clazosentan

N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-[2-(2H-tetrazol-5-yl)pyridin-4-yl]pyrimidin-4-yl]-5-methyl-pyridine-2-sulfonamide

C25H23N9O6S (577.1492)


C28313 - Endothelin Receptor Antagonist Clazosentan (Ro 61-1790) is a selective endothelin A (ETA) receptor antagonist. Clazosentan inhibits ET-1-mediated vasoconstriction. Clazosentan prevents cerebral vasospasm, vasospasm-related cerebral infarction[1][5].

   

Vitexin 2-O-beta-L-rhamnoside

Vitexin 2-O-beta-L-rhamnoside

C27H29O14- (577.1557)


   

CDP-N-methyl-L-glucosamine

CDP-N-methyl-L-glucosamine

C16H27N4O15P2- (577.0948)


   

pelargonidin 3-O-beta-D-p-coumaroylglucoside

pelargonidin 3-O-beta-D-p-coumaroylglucoside

C30H25O12- (577.1346)


   

cicerin-7-O-glucoside-6-malonate

cicerin-7-O-glucoside-6-malonate

C26H25O15- (577.1193)


   

6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]-7-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-5-olate

6-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2R,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]-7-hydroxy-2-(4-hydroxyphenyl)-4-oxochromen-5-olate

C27H29O14- (577.1557)


   

2-[[3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]-oxomethyl]imino-1-(2-methylpropyl)-5-oxo-3-dipyrido[1,2-d:3,4-f]pyrimidinecarboxylic acid ethyl ester

2-[[3-(2-Chloro-6-fluorophenyl)-5-methyl-4-isoxazolyl]-oxomethyl]imino-1-(2-methylpropyl)-5-oxo-3-dipyrido[1,2-d:3,4-f]pyrimidinecarboxylic acid ethyl ester

C29H25ClFN5O5 (577.1528)


   

(3S,3S,4R,5S)-5-(2-hydroxyethyl)-5-iodo-4-[(4-methoxyphenyl)-dimethylsilyl]-3-methyl-1-prop-2-enyl-2-spiro[indole-3,2-oxolane]one

(3S,3S,4R,5S)-5-(2-hydroxyethyl)-5-iodo-4-[(4-methoxyphenyl)-dimethylsilyl]-3-methyl-1-prop-2-enyl-2-spiro[indole-3,2-oxolane]one

C26H32INO4Si (577.1145)


   

vitexin 2-O-alpha-L-rhamnoside(1-)

vitexin 2-O-alpha-L-rhamnoside(1-)

C27H29O14- (577.1557)


The conjugate base of vitexin 2-O-alpha-L-rhamnoside arising from deprotonation of the OH group at position 7 on the chromene.

   

vitexin 2-O-beta-L-rhamnoside(1-)

vitexin 2-O-beta-L-rhamnoside(1-)

C27H29O14 (577.1557)


A flavonoid oxoanion that is the conjugate base of vitexin 2-O-beta-L-rhamnoside obtained by deprotonation of the OH group at position 7 on the chromene. It is the major microspecies at pH 7.3 (according to Marvin v 6.2.0.).